Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 1...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mansour, Ahmad M., Arevalo, J. Fernando, Al Kahtani, Eman, Zegarra, Hernando, Abboud, Emad, Anand, Rajiv, Ahmadieh, Hamid, Sisk, Robert A., Mirza, Salman, Tuncer, Samuray, Navea Tejerina, Amparo, Mataix, Jorge, Ascaso, Francisco J., Pulido, Jose S., Guthoff, Rainer, Goebel, Winfried, Roh, Young Jung, Banker, Alay S., Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y., Massoud, Vicky, Ghazi, Nicola G.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2014
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4132478/
https://ncbi.nlm.nih.gov/pubmed/25147732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/210458
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki